![FDA guidance restricts e-cigarette flavors, leaving tobacco and menthol on the market](https://cdn.cancerletter.com/media/2020/01/25191256/TCL46-01_Fruit_4x3.jpg)
![FDA guidance restricts e-cigarette flavors, leaving tobacco and menthol on the market](https://cdn.cancerletter.com/media/2020/01/25191256/TCL46-01_Fruit_4x3.jpg)
Cover Story
By Alexandria Carolan and Matthew Bin Han Ong
FDA Jan. 2 issued a final guidance that will restrict the sale of e-cigarette flavors most popular with minors.
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Clinical Roundup
Drugs & Targets
![Drugs & Targets](https://cdn.cancerletter.com/media/2019/05/03161633/targets2.jpg)
![Drugs & Targets](https://cdn.cancerletter.com/media/2019/05/03161633/targets2.jpg)
Trending Stories
- Before the Olympics were smoke-free, tobacco brand deals ran rampant
- Kamala Harris widely expected to continue Cancer Moonshot; Conservatives present their vision in Project 2025
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- ODAC vote will likely lead to three-arm and four-arm designs–and pragmatic trials–for perioperative indications
- Better oncology drug management could lead to improved outcomes, lower costs
- Tweaking the existing systems is not the answer to drug shortages